| RLAY Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the RLAY market cap history going back to 7/16/2020:
Also see: RLAY Shares Outstanding History and RLAY YTD Return |
RLAY Market Cap History — Relay Therapeutics Capitalization Over Time
As of 5/1/2026 Relay Therapeutics has a market cap of 2.44 billion. Investors often follow the RLAY market cap history to compare the size of the company over time.
This page shows RLAY market capitalization trends over time, with 25 market cap datapoints presented, dating back to 7/16/2020.
| RLAY Market Cap History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||
RLAY Historical Market Cap: -2.72% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||
| RLAY Stock Price Chart |
| About Relay Therapeutics Inc |
| Relay Therapeutics Inc. is a clinical-stage precision medicine company. Co. is focused on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. Co.'s Dynamo platform integrates an array of computational and experimental approaches designed to drug protein targets that have previously been intractable or inadequately addressed. Co.'s lead product candidates, such as RLY-2608, Lirafugratinib (RLY-4008), and Migoprotafib (GDC-1971). RLY-2608 is an allosteric, pan-mutant and isoform-selective phosphoinostide 3 kinase alphas (PI3K?), inhibitor. We show 25 historical shares outstanding datapoints in our RLAY shares outstanding history coverage, used to compute RLAY market cap on those dates. Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing RLAY market cap history over the course of time is important for investors interested in comparing RLAY's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of RLAY versus a peer is one thing; comparing RLAY market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like RLAY can fluctuate over the course of history. With this page we aim to empower investors researching RLAY by allowing them to research the RLAY market cap history. |
| RLAY Current Stock Quote |
Quotes delayed 20 minutes  Free RLAY Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: The Importance of Market Cap | |
|
Video: The Importance of Market Cap
| RLAY Share Performance |
| Market Cap Peers |
| Relay Therapeutics (RLAY) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:
RLMD Market Cap History RLYB Market Cap History RMD Market Cap History RMED Market Cap History RMTI Market Cap History RNA Market Cap History RNAC Market Cap History RNAZ Market Cap History RNTX Market Cap History RNXT Market Cap History More Healthcare companies » |
RLAY Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
